Dr. Lal Pathlabs Limited
|IPO Opens on||Dec 8, 2015|
|IPO Closes on||Dec 10, 2015|
|IPO Type||100% Book Built Issue|
|Equity Shares Offered||11600000 Equity Shares|
|Face Value of Shares||Rs 10 Per Equity Share|
|Price Band||Rs 540 – Rs 550 Per Equity Share|
|Market Lot||20 Shares|
|Issue Size||Rs 626.40 – 638 Crs|
|Listing on||BSE, NSE|
|Lead Managers||Kotak Mahindra Capital & Citigroup Global Markets|
|Object of the issue||
To achieve the benefits of listing the Equity Shares on the Stock Exchanges
For the sale of 11,600,000 Equity Shares by the Selling Shareholders.
Dr. Lal PathLabs Limited is a Delhi based provider of diagnostic and related healthcare tests and services in India. Through its nationwide network, company offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.
Company has built a national network consisting of its National Reference Laboratory in New Delhi, 171 clinical laboratories, 1554 patient service centers and over 7000 pickup points as of September 30, 2015.
Company’s customers include individual patients, hospitals and other healthcare providers and corporate customers.
It is a debt free company having internal accruals of Rs.235 Crs.
- Company offers 3,368 diagnostic and related healthcare tests.
- Company collected 21.8 million samples from 9.9 million patients in FY 2015.
- Company is well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry.
- Its centralized information technology platform fully integrates to it network and is scalable.
1. Dr. Arvind Lal
2. Dr. Vandana Lal
- Eskay House
Consolidated Financial Trend ~ Amt in Rs Crs
|Long Term Debt||–||–||–||–||4|